4.2 Article

Novel Mutations of the ALMS1 Gene in Patients with Alstrom Syndrome

Related references

Note: Only part of the references are listed.
Article Biochemistry & Molecular Biology

Genomic knockout of alms1 in zebrafish recapitulates Alstrom syndrome and provides insight into metabolic phenotypes

Jessica E. Nesmith et al.

HUMAN MOLECULAR GENETICS (2019)

Review Genetics & Heredity

ALMS1 and Alstrom syndrome: a recessive form of metabolic, neurosensory and cardiac deficits

Tom Hearn

JOURNAL OF MOLECULAR MEDICINE-JMM (2019)

Article Genetics & Heredity

Late diagnosis of Alstrom syndrome in a Yemenite-Jewish child

Shire Weiss et al.

OPHTHALMIC GENETICS (2019)

Article Endocrinology & Metabolism

Five novel ALMS1 gene mutations in six patients with Alstrom syndrome

Suna Kilinc et al.

JOURNAL OF PEDIATRIC ENDOCRINOLOGY & METABOLISM (2018)

Article Endocrinology & Metabolism

Whole exome sequencing identifies a homozygous nonsense variation in ALMS1 gene in a patient with syndromic obesity

Aneek Das Bhowmik et al.

OBESITY RESEARCH & CLINICAL PRACTICE (2017)

Review Physiology

Physiological and pathophysiological role of nonsense-mediated mRNA decay

Franziska Ottens et al.

PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2016)

Article Genetics & Heredity

Alstrom Syndrome: Mutation Spectrum of ALMS1

Jan D. Marshall et al.

HUMAN MUTATION (2015)

Article Biochemistry & Molecular Biology

I-TASSER server: new development for protein structure and function predictions

Jianyi Yang et al.

NUCLEIC ACIDS RESEARCH (2015)

Review Genetics & Heredity

Alstrom syndrome: current perspectives

Maria Alvarez-Satta et al.

APPLICATION OF CLINICAL GENETICS (2015)

Article Multidisciplinary Sciences

Mutations in Alstrom protein impair terminal differentiation of cardiomyocytes

Lincoln T. Shenje et al.

NATURE COMMUNICATIONS (2014)

Article Biochemistry & Molecular Biology

Alstrom Syndrome: Genetics and Clinical Overview

Jan D. Marshall et al.

CURRENT GENOMICS (2012)

Article Medicine, Research & Experimental

Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin

Liat Linde et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)